Germany's BioNTech plans UK trial of mRNA cancer therapy
German pharmaceutical company BioNTech, which developed a trailblazing Covid-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.. The company has been developing mRNA-based cancer therapies since it was founded in 2008 and they have been trialled on several hundred people so far. fec/hmn/lth